Última revisão: 31 Jun 2021
Última atualização: 02 Set 2020

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • sintomas de armazenamento
  • sintomas de micção

Outros fatores diagnósticos

  • febre com disúria
  • retenção urinária

Fatores de risco

  • idade superior a 50 anos
  • história familiar
  • raça não asiática
  • tabagismo
  • alopécia androgênica
  • síndrome metabólica

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • urinálise
  • antígeno prostático específico (PSA)
  • escore internacional de sintomas prostáticos (International Prostate Symptom Score)
  • escore de incômodo global
  • quadro de volume

Investigações a serem consideradas

  • ultrassonografia
  • tomografia computadorizada (TC) de abdome/pelve
  • cistoscopia
  • urofluxometria
  • estudo urodinâmico

Algoritmo de tratamento

Colaboradores

Autores

Michael T. Flannery, MD
Michael T. Flannery

Professor

Internal Medicine

University of South Florida College of Medicine

Department of Internal Medicine

Tampa

FL

Declarações

MTF declares that he has no competing interests.

Erika Abel, MD

Associate Professor and Program Director

Internal Medicine

University of South Florida College of Medicine

Department of Internal Medicine

Tampa

FL

Declarações

EA declares that she has no competing interests.

Revisores

Christopher R. Chapple, BSc, MD, FRCS (Urol), FEBU

Consultant Urological Surgeon

Royal Hallamshire Hospital

Honorary Senior Lecturer of Urology

University of Sheffield

Newcastle University

Visiting Professor of Urology

Sheffield Hallam University

Adjunct Secretary responsible for Education

European Association of Urology

Sheffield

UK

Declarações

CRC is Chairman of NICE Male LUTS Guidelines Development Group.

Robert Pickard, MD, FRCS (Urol)

Professor of Urology

Institute of Cellular Medicine

Newcastle University

Newcastle upon Tyne

UK

Declarações

RP has received funding from the UK NHS (NIHR) to undertake commissioned reviews of treatment for benign prostatic enlargement.

Steven K. Brooks, MD

Chief

Department of Surgery

South Seminole Hospital

Longwood

FL

Declarações

SKB is a member of the National Speakers Bureau for Boehringer Ingelheim, Astellas Pharmaceutics, and Glaxo Pharmaceuticals and has served as a consultant for these companies.

O uso deste conteúdo está sujeito ao nosso aviso legal